Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3038

Actual shortage: 237 (8%)
Anticipated shortage: 14 (0%)
Avoided shortage: 9 (0%)
Resolved: 2778 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2022-12-16 2023-03-16 178751
APO-LANSOPRAZOLE 15MG CAPSULE (DELAYED RELEASE) Resolved 2022-12-16 2023-01-26 178754
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-01-20 2023-01-26 181970
APO-LANSOPRAZOLE 15MG CAPSULE (DELAYED RELEASE) Resolved 2023-02-02 2023-03-16 183480
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-02-09 2023-03-16 184089
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-05-06 2023-05-26 191877
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-05-19 2023-06-09 192796
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-07-07 2023-09-15 197879
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-07-13 2023-11-06 198525
APO-LANSOPRAZOLE 15MG CAPSULE (DELAYED RELEASE) Resolved 2023-10-20 2023-11-06 207716
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-11-06 2023-11-24 209348
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-12-22 2024-02-02 214215
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2024-04-19 2024-05-03 225761
APO-LAMOTRIGINE 150MG TABLET Resolved 2019-01-03 2019-03-01 71130
APO-LAMOTRIGINE 150MG TABLET Resolved 2019-08-07 2019-08-21 91081
APO-LAMOTRIGINE 25MG TABLET Resolved 2019-09-04 2020-01-29 92978
APO-LAMOTRIGINE 100MG TABLET Resolved 2020-02-05 2020-03-27 105345
APO-LAMOTRIGINE 100MG TABLET TABLET Resolved 2020-05-08 2020-06-15 114288
APO-LAMOTRIGINE 150MG TABLET Resolved 2020-10-28 2020-12-07 127347
APO-LAMOTRIGINE 100MG TABLET TABLET Resolved 2020-12-11 2021-02-01 130045

Showing 1681 to 1700 of 3038

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-AMITRIPTYLINE 10MG TABLET Discontinued 2019-01-04 2019-01-04 71348
APO-AMITRIPTYLINE 25MG TABLET Discontinued 2019-01-04 2019-02-13 71351
APO-AMITRIPTYLINE 50MG TABLET To be discontinued 2019-01-04 2021-06-05 71354
APO-ALMOTRIPTAN Discontinued 2019-05-13 2019-05-13 83971
APO-ALMOTRIPTAN Discontinued 2019-05-13 2019-05-13 83976
APO-ALENDRONATE 10MG TABLET To be discontinued 2018-09-07 2019-12-20 60163
APO-ALENDRONATE 5MG TABLET Discontinued 2019-01-03 2019-12-21 71023
APO-ALENDRONATE 10MG TABLET To be discontinued 2019-01-03 2019-12-20 71026
APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH 500MG TABLET Discontinued 2018-09-07 2018-09-08 60157
APO-ACEBUTOLOL 400MG TABLET Discontinued 2017-03-31 2018-02-05 4965
APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE 300MG 150MG 300MG TABLET Discontinued 2022-12-12 2022-12-12 177953
APO TRIAZIDE 50MG 25MG TABLET Discontinued 2018-09-08 2019-02-13 60837
APO PREDNISONE TAB 5MG 5MG TABLET Discontinued 2018-09-08 2018-12-28 60699
APO PREDNISONE TAB 1MG USP 1MG TABLET Discontinued 2017-03-13 2017-03-13 1056
APO PEN VK Discontinued 2019-03-08 2019-03-08 78141
APO PEN VK Discontinued 2019-03-08 2019-03-08 78144
APO-OXAZEPAM 30MG TABLET Discontinued 2018-09-08 2019-06-12 60681
APO-OXAZEPAM 15MG TABLET To be discontinued 2018-09-08 2018-09-08 60678
APO-OXAZEPAM 10MG TABLET Discontinued 2018-09-08 2019-08-30 60675
APO-NAPROXEN 250MG TABLET Discontinued 2017-03-30 2018-02-05 4734

Showing 301 to 320 of 356